CTOs on the Move

Axonics Modulation Technologies

www.axonics.com

 
Axonics Modulation Technologies, Inc is a privately-held medical device company developing an innovative neuromodulation platform based on a miniaturized rechargeable fully-implantable IPG licensed from the Alfred Mann Foundation. The Axonics Sacral Neuromodulation System is designed to improve the experience of both clinicians and patients suffering from Urinary and Fecal dysfunction.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million
  • www.axonics.com
  • 7575 Irvine Center Drive Suite 200
    Irvine, CA USA 92618
  • Phone: 949.396.6322

Executives

Name Title Contact Details

Funding

Axonics Modulation Technologies raised $38.5M on 12/22/2015
Axonics Modulation Technologies raised $14.5M on 05/02/2017
Axonics Modulation Technologies raised $20.5M on 07/06/2017
Axonics Modulation Technologies raised $20M on 04/03/2018
Axonics Modulation Technologies raised $110M on 11/22/2019
Axonics Modulation Technologies raised $17M on 12/13/2019
Axonics Modulation Technologies raised $201.3M on 05/14/2021

Similar Companies

Home Care Specialists

Home Care Specialists is a Haverhill, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EXAKT Technologies

EXAKT Technologies is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Litigation

Medical Litigation is a Lancaster, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PartsSource

PartsSource is the nation`s only multi-modality, multi-vendor supplier of medical replacement parts.

Neuronetics

Neuronetics, Inc. believes that mental health is as important as physical health. As a global leader in neuroscience, Neuronetics is redefining patient and physician expectations with its NeuroStar Advanced Therapy for Mental Health. NeuroStar is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions when traditional medication hasn`t helped. NeuroStar is FDA-cleared for adults with major depressive disorder (MDD), as an adjunct for adults with obsessive-compulsive disorder (OCD), and to decrease anxiety symptoms in adult patients with MDD that may exhibit comorbid anxiety symptoms (anxious depression). NeuroStar Advanced Therapy is the leading transcranial magnetic stimulation (TMS) treatment for MDD in adults with over 5 million treatments delivered. NeuroStar is backed by the largest clinical data set of any TMS system for depression, including the world`s largest depression Outcomes Registry. Neuronetics is committed to transforming lives by offering an exceptional treatment that produces extraordinary results.